P & T : a Peer-reviewed Journal for Formulary Management
Overview
P & T is a peer-reviewed journal dedicated to formulary management, providing evidence-based insights on drug selection, utilization, and cost-effectiveness. It offers a platform for healthcare professionals to stay updated on the latest research, guidelines, and strategies for optimizing formulary decisions, improving patient outcomes, and managing healthcare costs.
Details
Details
Abbr.
P T
Start
1990
End
2019
Frequency
Monthly
p-ISSN
1052-1372
Country
United States
Language
English
Specialty
Pharmacology
Recent Articles
11.
Blow C, Probst L, Miller C, Seabury R
P T
. 2019 Sep;
44(9):533.
PMID: 31485145
No abstract available.
12.
Momin J, Candidate P, Hughes G
P T
. 2019 Sep;
44(9):530-549.
PMID: 31485144
Andexanet alfa (Andexxa) for the reversal of direct oral anticoagulants.
13.
Choy M
P T
. 2019 Sep;
44(9):527-529.
PMID: 31485143
Alpelisib (Piqray) for HR-positive/HER2-negative, PIK3CA-mutated, advanced/ metastatic breast cancer; polatuzumab vedotin-piiq (Polivy) for diffuse large B-cell lymphoma; and eculizumab (Soliris) for neuromyelitis optica spectrum disorder.
14.
P T
. 2019 Sep;
44(9):517-566.
PMID: 31485142
Approvals, new indications and formulations, and safety issues.
15.
Barlas S
P T
. 2019 Sep;
44(9):516-533.
PMID: 31485141
The legal tactics that drug manufacturers use to extend drug patents may be the biggest impediment to lowering drug prices and to Congress acting on pricing. Until now, that is.
16.
Grissinger M
P T
. 2019 Sep;
44(9):514-515.
PMID: 31485140
We present technology enhancements that support the safe use of U-500 insulin.
17.
18.
19.
20.